Bladder cancer immunotherapy parallel advances in BCG optimization and next-generation vaccine platforms
Bladder cancer (BCa) remains a significant global health challenge with rising incidence and suboptimal outcomes in advanced stages. Although immunotherapy for urological cancers is not a new treatment, recent clinical advances have confirmed the value…